See more : SciVision Biotech Inc. (1786.TW) Income Statement Analysis – Financial Results
Complete financial analysis of Abingdon Health Plc (ABDX.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Abingdon Health Plc, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- Intercontinental Exchange, Inc. (ICE) Income Statement Analysis – Financial Results
- OmniLit Acquisition Corp. (OLITU) Income Statement Analysis – Financial Results
- Loncin Motor Co., Ltd. (603766.SS) Income Statement Analysis – Financial Results
- Getinge AB (publ) (0GZV.IL) Income Statement Analysis – Financial Results
- MAS Gold Corp. (MSGCF) Income Statement Analysis – Financial Results
Abingdon Health Plc (ABDX.L)
About Abingdon Health Plc
Abingdon Health Plc develops, manufactures, and distributes diagnostic devices worldwide. It offers AbC-19 Rapid Test, a COVID-19 IgG rapid antibody test; nucleic acid lateral flow immunoassays; Seralite, a rapid lateral flow test for the quantitative measurement of kappa and lambda immunoglobulin free light chains in serum; and AppDx, a customizable image capturing technology that transforms a smartphone into a self-sufficient and standalone lateral-flow reader. The company also provides lateral flow development and manufacturing services. Additionally, it provides consultancy services to businesses in the healthcare technology sector. The company has a collaboration and co-marketing agreement with Abcam plc. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 6.14M | 4.05M | 2.84M | 11.62M | 5.24M | 2.28M | 2.27M |
| Cost of Revenue | 2.46M | 2.64M | 8.06M | 8.22M | 1.15M | 705.38K | 924.61K |
| Gross Profit | 3.68M | 1.40M | -5.23M | 3.39M | 4.09M | 1.57M | 1.34M |
| Gross Profit Ratio | 59.97% | 34.66% | -184.44% | 29.21% | 78.05% | 69.03% | 59.24% |
| Research & Development | 0.00 | 0.00 | 182.00K | 503.00K | 854.00K | 210.73K | 285.04K |
| General & Administrative | 5.07M | 5.22M | 6.65M | 7.55M | 3.37M | 3.02M | 0.00 |
| Selling & Marketing | 48.00K | 28.00K | 49.00K | 864.00K | 36.00K | 0.00 | 0.00 |
| SG&A | 5.12M | 5.25M | 6.69M | 8.41M | 3.40M | 3.02M | 5.76M |
| Other Expenses | -66.00K | 450.00K | 0.00 | 0.00 | 0.00 | -55.35K | 0.00 |
| Operating Expenses | 5.05M | 5.25M | 6.88M | 8.91M | 7.40M | 2.97M | 6.05M |
| Cost & Expenses | 7.51M | 7.89M | 14.94M | 17.14M | 8.55M | 3.67M | 6.97M |
| Interest Income | 31.00K | 89.00K | 4.00K | 234.00K | 63.00K | 3.48K | 8.68K |
| Interest Expense | 57.00K | 72.00K | 69.00K | 234.00K | 64.35K | 22.43K | 4.39M |
| Depreciation & Amortization | 426.00K | 673.00K | 1.64M | 749.00K | 591.67K | 289.15K | 680.74K |
| EBITDA | -916.00K | -2.81M | -19.98M | -6.07M | -2.84M | -1.10M | 8.00M |
| EBITDA Ratio | -14.93% | -78.44% | -369.24% | -41.07% | 5.31% | -48.43% | -177.33% |
| Operating Income | -1.37M | -3.85M | -12.11M | -5.52M | 217.00K | -1.40M | -4.70M |
| Operating Income Ratio | -22.38% | -95.08% | -426.98% | -47.51% | 4.15% | -61.28% | -207.34% |
| Total Other Income/Expenses | -26.00K | 14.00K | -65.00K | -234.00K | -63.00K | -18.95K | 7.64M |
| Income Before Tax | -1.40M | -3.81M | -21.69M | -7.05M | -3.38M | -1.41M | 2.93M |
| Income Before Tax Ratio | -22.80% | -94.09% | -764.90% | -60.72% | -64.47% | -62.11% | 129.33% |
| Income Tax Expense | -128.00K | -355.00K | -423.00K | -81.00K | 1.00K | -154.31K | -535.53K |
| Net Income | -1.27M | -3.45M | -21.26M | -6.97M | -3.37M | -1.26M | 3.47M |
| Net Income Ratio | -20.72% | -85.32% | -749.98% | -60.02% | -64.45% | -55.33% | 152.95% |
| EPS | 0.00 | -0.01 | -0.07 | -0.07 | -0.04 | -0.01 | 0.04 |
| EPS Diluted | 0.00 | -0.01 | -0.07 | -0.07 | -0.04 | -0.01 | 0.04 |
| Weighted Avg Shares Out | 304.73M | 304.03M | 291.62M | 95.98M | 95.98M | 95.98M | 95.98M |
| Weighted Avg Shares Out (Dil) | 304.73M | 305.82M | 291.62M | 95.98M | 95.98M | 95.98M | 95.98M |
Source: https://incomestatements.info
Category: Stock Reports